Drug intelligence / Profile preview

autologous salivary gland stem cells

Development stage
Unknown
Lead developer
University Medical Center Groningen
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intraglandular
01

Overview

Autologous salivary gland stem cells are an experimental cell therapy developed by the Universitair Medisch Centrum Groningen (UMCG) for the treatment of xerostomia (dry mouth) and salivary gland hypofunction, typically resulting from radiotherapy for head and neck cancer. The procedure involves harvesting a small biopsy of the patient's salivary gland tissue prior to radiation treatment. Stem and progenitor cells (often characterized by markers like c-Kit or CD117) are isolated, expanded in vitro, and subsequently transplanted back into the patient's damaged salivary glands. The mechanism of action relies on the ability of these stem cells to differentiate into functional acinar cells and provide paracrine support, thereby regenerating the secretory tissue and restoring saliva production.

Other names
SaliStemautologous salivary gland-derived stem cellssalivary gland stem/progenitor cells

Beyond the preview

Go deeper on autologous salivary gland stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous salivary gland stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call